Search clinical trials for: Обычное лечение (TAU)

Total 3459 results

Takeda

Completed

Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants

Japanese Healthy Adult Male Participants

Japan
Takeda

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy Participants

Healthy Participants

United States
Takeda

Completed

A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) Tablet

Japanese Healthy Adult Male

Japan
Takeda

Completed

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Oral Single Dose of TAK-418 in Healthy Participants

Healthy Participants

United States
Cornell University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Nudging Nutrition With Monetary Incentives Environmental Cues

Obesity | Diet | Health Behavior | Food Labeling

United States
Takeda

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-438 in Healthy Male Participants

Dose Finding Study
Takeda

Completed

TAK-020 Relative Bioavailability and Food Effect Study in Healthy Participants

Healthy

United Kingdom
Takeda

Withdrawn

A Phase 1, Single and Multiple Dose Study of TAK-137

Healthy Japanese Adult Male

Japan
Chong Kun Dang Pharmaceutical

Unknown

A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers (CKD-333)

Cardiovascular Diseases
University Hospital, Montpellier

Recruiting

RESist Against Irritability Superiority Trial (RESIST)

Irritable Mood

France
Butler Hospital
American Foundation for Suicide Prevention (AFSP)

Not yet recruiting

Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Randomized Trial

Suicidal Ideation | Suicide, Attempted | Suicide | Suicide and Self-harm

United States
VA Office of Research and Development

Recruiting

Evaluating the Use of Peer Specialists to Deliver Cognitive Behavioral Social Skills Training (CBSST-PEER)

Serious Mental Illness

United States
Université de Sherbrooke
Canadian Institutes of Health Research (CIHR); Relief

Active, not recruiting

Clinical Trial of a Group Self-management Support Program for Anxiety Disorders

Generalized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder | Agoraphobia

Canada
Takeda
Takeda Development Center Americas, Inc.

Terminated

A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery

Crohn Disease

United States, Germany, Austria, France, United Kingdom
Johns Hopkins University

Terminated

Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy

Diabetic Retinopathy | Stargardt Disease | Macular Degeneration (Age Related)

United States
Neurocrine Biosciences
Takeda

Completed

A Study to Evaluate the Relative Bioavailability (BA) and Effect of Food on TAK-831 Tablet Formulations in Healthy Participants

Healthy Volunteers

United States
Millennium Pharmaceuticals, Inc.

Terminated

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female Participants

Healthy Volunteers

United States
Pfizer

Terminated

A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin

Cachexia

United States
University of Buenos Aires

Recruiting

CALMA App as an Adjunct to Therapy for Reduction of Suicidal and Non-Suicidal Self-Injurious Behaviors in Adolescents

Self-Injurious Behavior

Argentina
Yale University
National Center for Advancing Translational Sciences (NCATS)

Recruiting

Coordinating Opioid Use Treatment Through Medical Management With Infection Treatment (Project COMMIT) (COMMIT)

Opioid-use Disorder

United States
Syracuse VA Medical Center
VA Office of Research and Development; Michael E. DeBakey VA Medical Center

Completed

ACT Workshops: A Novel Delivery Modality to Increase Access to Care for Rural Veterans

Psychological Distress | Access to Care

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Computer Based Training in Cognitive Behavioral Therapy Web-based (Man VS Machine)

Substance Abuse

United States
Karolinska Institutet
Region Stockholm

Completed

CBT Through Internet and Smartphones for Adults With ADHD - a Randomized Controlled Trial (Ad5)

ADHD

Sweden
Massachusetts General Hospital
National Institute of Mental Health (NIMH); The Fenway Institute

Unknown

Body Image and Self-Care in HIV-Infected MSM (BUILD)

Medication Adherence | Body Image Disturbance

United States
Central Institute of Mental Health, Mannheim

Active, not recruiting

Validation of a Training Program for Patients With Alcohol Use Disorder

Alcohol Use Disorder

Germany
University of New Mexico
National Institute on Drug Abuse (NIDA)

Completed

A Randomized Controlled Trial of Culturally Adapted Evidence-based Treatment With a Southwest Tribe (MICRA)

Substance Use Disorders
University of Texas Southwestern Medical Center
University of Pittsburgh; American Foundation for Suicide Prevention

Completed

Establishing Efficacy of an Inpatient Intervention and Phone App to Reduce Suicidal Risk (ASAP+BRITE)

Suicidal Ideation | Suicide, Attempted

United States
Hospital de Clinicas de Porto Alegre

Unknown

EMDR in Adolescents With Bipolar Disorder and History of Trauma

Bipolar Disorder

Brazil
University of California, Los Angeles
University of Colorado, Boulder

Completed

Evaluating the Effectiveness of Family-Focused Psychoeducation in Treating Adolescents With Bipolar Disorder

Bipolar Disorder

United States
Ankara City Hospital Bilkent

Completed

Comparison of Two Different Approach TAP Block on Pain Management of Laparoscopic Nephrectomy

Postoperative Pain, Acute | Analgesia, Patient-Controlled

Turkey
Takeda

Completed

A Study of TAK-079 in People With Generalized Myasthenia Gravis

Myasthenia Gravis

United States, Spain, Canada, Serbia, Italy, Poland
Indiana University
Halyard Health

Completed

Single-shot TAP Block vs Continuous TAP Block (TAP)

Postoperative Pain

United States
Takeda

Completed

A Study of TAK-105 in Healthy Adults

Healthy Volunteers

United States
Duke University
National Institute of Mental Health (NIMH)

Recruiting

Comprehensive Adaptive Multisite Prevention of University Student Suicide (CAMPUS)

Suicide

United States
Millennium Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus | Lupus Erythematosus, Systemic

United States
Takeda
Takeda Development Center Americas, Inc.

Completed

A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery

Postoperative Gastrointestinal Dysfunction

United States, Germany
Neurocrine Biosciences
Takeda

Completed

Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study

Schizophrenia | Healthy Volunteers

United States
Neurocrine Biosciences
Takeda

Completed

TAK-653 Escalating Single and Multiple Dose Study in Healthy Participants

Depressive Disorder

United Kingdom
Millennium Pharmaceuticals, Inc.

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-954 in Healthy Adult Participants

Healthy Volunteers

United States
Takeda

Completed

Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants

Schizophrenia

United States
Takeda

Terminated

Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes (GRAND-307)

Type 2 Diabetes Mellitus

Taiwan, China, Korea, Republic of, New Zealand, Australia
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma (HCC)

China
Takeda

Completed

TAK-438 - Safety, Blood Levels & Effects of Repeated Doses (TAK-438_107)

Gastroesophageal Reflux Disease (GERD) | Erosive Esophagitis(EE)

United Kingdom
Harvard University Faculty of Medicine
Beth Israel Deaconess Medical Center; Brigham and Women's Hospital

Completed

Tai Chi, Physiologic Complexity, and Healthy Aging

Healthy Aging

United States
Takeda

Withdrawn

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults

Coronavirus Disease
Dong-A ST Co., Ltd.

Not yet recruiting

Bioequivalence Study Between "DA-5215 Tab" and "DA-5215-R Tab"

Healthy

Korea, Republic of
IRCCS San Raffaele

Recruiting

Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach

Mood Disorders | Major Depressive Disorder

Italy
University of Oslo
Oslo University Hospital

Completed

Psychological Interventions to Prevent Late Effects in Breast Cancer (PREVENT)

Pain, Postoperative | Breast Cancer | Fatigue

Norway
Johannes Gutenberg University Mainz

Completed

Psychodynamic Motivation and Training Program (PMT)

Physical Activity | Coronary Heart Disease

Germany
University of Hawaii

Recruiting

Natives Engaged in Alzheimers Research - 'Ike Kupuna (NEAR)

Mild Cognitive Impairment | Subjective Cognitive Impairment

United States

Search clinical trials for: Обычное лечение (TAU)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations